RxDoctor Payments Data

David Malis, MD

Pediatric Otolaryngology · Melbourne, FLNPI 1649242538

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (44.1%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Integra Lifesciences Corporation at 51.6% of the total. Reporting peaked in 2024 at $2,126 and has fallen 84.0% since, to $340 in 2025. Among pediatric otolaryngology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,952in general payments, 2019–2025

Across 46 payments — averaging $85.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$2K
  • AbbVie$932
  • Optinose US, Inc.$395
  • Acclarent, Inc$211
  • Phadia US Inc.$70
  • Novartis$49
  • plus $255 from 8 others

What the payments were for

  • Travel & lodging$1,74144%
  • Food & beverage$1,27932%
  • Gifts$93224%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,952 in reported general payments places this provider in the 90th percentile of 53 pediatric otolaryngology providers in Florida.

See all pediatric otolaryngology providers in Florida

Medicare billing

Part B allowed, 2024
$67,158
Medicare patients
222
Services billed
752

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluocinolone Acetonide Oil73$4,280
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth26$2,785
Fluticasone Propionate43$483
Ipratropium Bromide19$437
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$145
Prednisone15$16

Paid to pharmacies, not to this prescriber.

Other pediatric otolaryngology in Melbourne

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →